ATTR Amyloidosis Patisiran Treatment Medication Savings with TheDrugClub
Members can check active-formulary eligibility and membership pricing for ATTR Amyloidosis Patisiran Treatment medications. A condition association alone does not establish coverage.
What Is ATTR Amyloidosis Patisiran Treatment?
ATTR Amyloidosis Patisiran Treatment is a medical condition that may require prescription treatment. Consult a healthcare professional about appropriate options.
Managing ATTR Amyloidosis Patisiran Treatment with TheDrugClub
Eligible medications linked to the active formulary may have no additional cost under listed supply, quantity, fill, and fulfillment limits. Other prescriptions may qualify for membership pricing. Confirm current terms before filling.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
About ATTR Amyloidosis Patisiran Treatment
ATTR amyloidosis is a rare, progressive condition caused by misfolded proteins accumulating in vital organs, often requiring specialized and costly treatments like Patisiran. Managing this disease can be challenging, but TheDrugClub is dedicated to helping individuals and families afford their essential prescriptions, ensuring access to the care you need without financial strain.
Understanding ATTR Amyloidosis
Amyloidosis is a group of rare diseases caused by an abnormal protein, called amyloid, building up in organs and tissues throughout the body. Transthyretin (ATTR) amyloidosis specifically involves the transthyretin (TTR) protein. When TTR misfolds, it forms amyloid deposits that can severely damage the heart, nerves, kidneys, and other organs.
There are two main types of ATTR amyloidosis: hereditary (hATTR), which is passed down through families due to a genetic mutation, and wild-type (wtATTR), which is age-related and occurs without a known genetic cause. Symptoms can vary widely but often include neuropathy (nerve damage leading to numbness, tingling, and pain), cardiomyopathy (heart muscle disease causing shortness of breath and fatigue), and issues with digestion or vision. Early diagnosis and treatment are crucial to slow disease progression and manage symptoms.
Patisiran and Other Treatments
Treatments for ATTR amyloidosis aim to reduce the production of the abnormal TTR protein or remove existing amyloid deposits. Patisiran (marketed as On
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.